Medical specialists from France tagged as investigators in clinical trials studying Hyperplasia

Total 62 results

Alexandre de la Taille, Pr.
Seen in:
- Créteil, CHU Henri Mondor
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Ambroise Salin, Dr.
Seen in:
- Quint-Fonsegrives, Clinique La Croix du Sud
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Benjamin Pradère, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Brannwel Tibi, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Sub-Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Camille Overs, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Caroline Thuillier, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Sub-Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Charles Ballereau, Dr
Seen in:
- Lille, Hôpital Privé La Louvière
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
- NCT04838769 (Principal Investigator)
Conditions:
Charles BEHR
Seen in:
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:
- NCT03321240 (Sub-Investigator)
Conditions:
Edouard HIRSCH
Seen in:
- Strasbourg, Hôpitaux universitaires de Strasbourg
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:
- NCT03321240 (Principal Investigator)
- NCT06105645 (Principal Investigator)
Conditions:
Emmanuel Della Negra, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Eric Barret, Dr.
Seen in:
- Paris, Institut Mutualiste Montsouris
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Eric Oksenhendler, MD
Seen in:
- Paris, Hôpital Saint-Louis
Trials:
- NCT02817997 (Principal Investigator)
Conditions:
Evanguelos Xylinas, Dr
Seen in:
- Paris, Hopital Bichat
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Sub-Investigator)
- NCT04838769 (Principal Investigator)
Conditions:
Florian Laclergerie, Dr.
Seen in:
- Toulouse, CHU de Toulouse
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Franck Bruyère, Pr
Seen in:
- Amiens, Amiens university hospital
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
- NCT05415631 (Principal Investigator)
Conditions:
Gaëlle Fiard, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Sub-Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Georg Dorfmüller, MD
Seen in:
- Paris, Fondation Ophtalmologique Adolphe de Rothschld
Trials:
- NCT02890641 (Principal Investigator)
Conditions:
Gilles Karsenty, Pr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Grégoire Robert, Pr.
Seen in:
- Bordeaux, CHU de Bordeaux
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Hakim Fassi-Fehri, Dr.
Seen in:
- Lyon, Hospices Civils De Lyon
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Héloïse Ducousso, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Sub-Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Idir Ouzaid, Dr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Ismaël Galliot, Dr.
Seen in:
- Rouen, Clinique Saint Hilaire
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Jean-Alexandre Long, Pr.
Seen in:
- Grenoble, Chu Grenoble
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Jean-Luc Descotes, Pr
Seen in:
- Toulouse, Clinique Pasteur
Trials:
- NCT03297281 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia;
- Anticoagulant Adverse Reaction
Jean-Nicolas Cornu, Pr.
Seen in:
- Rouen, CHU de Rouen
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Jonathan Olivier, Dr.
Seen in:
- Lille, Centre Hospitalier Universitaire de Lille
Trials:
- NCT04838769 (Principal Investigator)
Conditions:
- Benign Prostatic Hyperplasia (BPH)
Louis TERRIOU, MD
Seen in:
- Lille, Hematology Unit CHRU Lille
- Nord, Lille, Hopital Cl Huriez
Trials:
- NCT02817997 (Principal Investigator)
- NCT01976182 (Principal Investigator)
Conditions:

Clinical Trials on Hyperplasia

University of Pennsylvania
Food and Drug Administration (FDA); EUSA Pharma, Inc.; Castleman Disease Collaborative...

Recruiting

International Registry for Patients With Castleman Disease (ACCELERATE)

Castleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymph Node Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNH | Hyperplasia, Giant Lymph Node | Lymph Node Hyperplasia, Giant

United States
St. Joseph's Healthcare Hamilton
Ontario Ministry of Health and Long Term Care

Completed

PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate (PVP)

Benign Prostatic Hyperplasia

Canada
GlaxoSmithKline

Completed

Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia

Benign Prostatic Hyperplasia
Castleman Disease Collaborative Network

Withdrawn

Castleman Disease Collaborative Network Biobank ("Castlebank")

Hyperplasia | Castleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymph Node Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNH | Giant Lymph Node

United States
Samsung Medical Center

Completed

Superb Microvascular Imaging in Focal Nodular Hyperplasia

Focal Nodular Hyperplasia

Korea, Republic of
GCS Ramsay Santé pour l'Enseignement et la Recherche

Not yet recruiting

Ejaculation Preservation After Laser Enucleation Prostate (EPALEP)

Prostate Hyperplasia

France
Hongguo Rong

Not yet recruiting

Clinical Study on the Treatment of Breast Hyperplasia With Kou Sha Therapy Based on Real World

Breast Hyperplasia
SB Istanbul Education and Research Hospital

Unknown

"Parathyroid Tissues Anatomic Localizations Are Displaced Downward in Parathyroid Hyperplasia Cases"

Parathyroid Hyperplasia
University of Pennsylvania
Castleman Disease Collaborative Network

Completed

Unlock the Cell: Castleman's Disease Flow Cytometry Study

Hyperplasia | Castleman Disease | Castleman's Disease | Giant Lymph Node Hyperplasia | Angiofollicular Lymph Hyperplasia | Angiofollicular Lymphoid Hyperplasia | GLNH

United States
Societatea Romana de Ultrasonografie in Medicina...
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian... and other collaborators

Unknown

Contrast Enhanced Ultrasound For The Evaluation Of Focal Liver Lesions (HepFocUS)

Liver Metastases | Focal Nodular Hyperplasia of Liver | Toxic Liver Disease With Focal Nodular Hyperplasia

Romania

Medical specialists from France tagged as investigators in clinical trials studying Hyperplasia

Clinical Trials on Hyperplasia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations